10-Q: First Choice Healthcare Reports Q3 Loss, Cash Dwindles

First Choice Healthcare Solutions, Inc. reported a net loss of $3.5 million for the nine months ended September 30, 2025, with cash reserves significantly depleted and a going concern warning.

Summary

• Net loss for the nine months ended September 30, 2025, was $3,500,214, an 11.5% decrease from $3,954,535 in the prior year.
• Cash and cash equivalents significantly decreased to $2,430 as of September 30, 2025, from $19,915 at December 31, 2024.
• Total current assets fell to $3,603 from $92,185, while total current liabilities increased to $37,160,986 from $33,274,182.
• The company has a working capital deficit and has generated recurring net losses since its emergence from bankruptcy in April 2022.
• Operating expenses increased to $1,785,720 for the nine months ended September 30, 2025, from $1,405,973 in the prior year, partly due to new rent expenses in Minnesota.
• Net cash used in operating activities was $552,485 for the nine months ended September 30, 2025, a significant negative shift from $685,385 cash provided in the prior year.
• The company received full forgiveness for a Paycheck Protection Plan (PPP) loan totaling $471,300 on April 24, 2025.

Sentiment

Score: 2

Explanation: The company faces severe liquidity issues with minimal cash, a substantial working capital deficit, and recurring net losses. The explicit 'going concern' warning, coupled with a significant negative shift in cash from operations and increasing liabilities, indicates a highly precarious financial position despite a slight reduction in net loss due to decreased interest expense and PPP loan forgiveness.

Positives

• Net loss decreased by 11.5% to $3,500,214 for the nine months ended September 30, 2025, compared to $3,954,535 in the prior year.
• Interest expense decreased to $2,143,153 for the nine months ended September 30, 2025, from $2,464,387 in the prior year.
• The company received full forgiveness for a PPP loan totaling $471,300 on April 24, 2025.
• Revenue, though still very low, increased to $5,686 for the nine months ended September 30, 2025, from a negative $19,801 in the prior year, primarily due to a 2024 write-off.

Negatives

• Cash and cash equivalents significantly decreased to $2,430 as of September 30, 2025, from $19,915 at December 31, 2024.
• Total current assets plummeted to $3,603 from $92,185, indicating severe liquidity issues.
• Total current liabilities increased to $37,160,986 from $33,274,182, exacerbating the working capital deficit.
• Net cash used in operating activities was $552,485 for the nine months ended September 30, 2025, a negative shift from $685,385 cash provided in the prior year.
• Operating expenses increased to $1,785,720 for the nine months ended September 30, 2025, from $1,405,973 in the prior year.
• The company has a substantial accumulated deficit of $71,281,363 as of September 30, 2025.
• A remaining accounts payable liability of approximately $1,200,000 exists from a 2021 lease settlement, which the company is working to settle.

Risks

• The company has a working capital deficit and has generated recurring net losses since its emergence from bankruptcy in April 2022, raising substantial doubt about its ability to continue as a going concern.
• Challenges in operating and restructuring due to previous issues in the healthcare market, including growing referral bases and negotiating favorable contract rates with third-party payors.
• Negative impact of the CEO indictment in November 2018 and the bankruptcy from June 2020, leading to litigation and damage to relationships with employees and referral sources.
• Dependence on acquiring profitable companies, growing revenue, reducing operating costs, and accessing additional capital to continue operations.
• Inability to secure additional capital may force the company to curtail business development initiatives and further reduce costs.
• General risk of lawsuits and legal proceedings in the ordinary course of business, with potential liabilities exceeding insurance coverage.
• Convertible notes payable are past due, though default provisions have been waived.

Future Outlook

The company's ability to continue as a going concern is dependent on successfully acquiring profitable companies, growing its revenue base, reducing operating costs, and securing additional capital through public or private equity offerings, debt financing, or corporate collaborations. Management believes it will be successful in repairing relationships and generating growth, but there is no assurance these plans will be achieved, and additional cost reductions may be necessary.

Management Comments

• Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.
• The Company believes that the current cash balance as of September 30, 2025, along with the continued execution of its business development plan, will allow the Company to further improve its working capital.
• The Company believes that it will be successful in repairing its relationships with employees and referral sources, generating growth and improved profitability resulting in improved cash flows from operations.
• Our opinion is that inflation has not had, and is not expected to have, a material effect on our operations.
• Our Chief Executive Officer and Principal Accounting Officer concluded that our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure.

Industry Context

First Choice Healthcare Solutions operates in the integrated healthcare services sector, focusing on primary care, anti-aging, and specialized therapies. The industry is characterized by evolving healthcare laws, regulations, and changes in third-party reimbursement rates. The company's strategy to build a network of localized platforms aligns with a trend towards community-based, comprehensive care, but its historical challenges, including a CEO indictment and bankruptcy, suggest significant internal hurdles that may prevent it from capitalizing on broader industry growth or competing effectively with more established or better-funded players.

Legal Proceedings

• The company is not currently a party to any pending legal proceedings that are not in the ordinary course of business or otherwise material to its financial condition.
• There is a general risk of litigation and potential liabilities exceeding insurance coverage, which could materially adversely affect the business.

Related Party Transactions

• Other Non-Convertible Notes include $2,142,105 due to the company's Chief Executive Officer and $151,858 due to the company's prior Chief Financial Officer, related to deferred compensation, payments to third-party service providers, and normal course of business items.
• Lance Friedman, the Chief Executive Officer, holds all 4 outstanding shares of Series A Super Voting Preferred Stock, which provides him with effective voting control of the company.

Stakeholder Impact

• Shareholders: Face significant dilution risk from potential future capital raises, substantial doubt about the company's ability to continue as a going concern, and continued losses. The CEO's super-voting shares also limit common shareholder influence.
• Employees: Headcount reductions have occurred in the past (October 2021, January 2023), and further reductions may be necessary if additional capital is not secured.
• Creditors: Convertible notes are past due, although default provisions have been waived. The company's precarious financial position increases credit risk.
• Customers/Patients: The company's financial instability and past issues (CEO indictment, bankruptcy) could impact service continuity and quality, though the filing doesn't directly address this.
• Suppliers: The increase in accounts payable and accrued expenses suggests potential payment delays or strain on supplier relationships.

Next Steps

• Acquire profitable companies.
• Grow the revenue base.
• Reduce operating costs, especially related to provider services.
• Access additional sources of capital (public/private equity, debt, collaborations).
• Potentially sell assets.
• Repair relationships with employees and referral sources.
• Work to reach a settlement for the remaining $1,200,000 accounts payable liability from the Marina Towers lease.

Key Dates

Recommendation

The company is in a highly distressed financial state, evidenced by critically low cash reserves ($2,430), a massive working capital deficit, and a significant negative shift in cash flow from operations. The explicit 'going concern' warning indicates a high probability of financial distress or failure without substantial, unassured capital infusion. While net loss decreased slightly, this was largely due to non-recurring PPP loan forgiveness and reduced interest expense, not improved core operations. The company's revenue remains negligible, and operating expenses are increasing. The CEO's super-voting shares also present a corporate governance concern for common shareholders. Given the severe liquidity crisis, recurring losses, and the 'going concern' doubt, the stock represents an extremely high-risk investment with a strong likelihood of further value erosion.

Keywords

Healthcare Services, Primary Care, SEC Filing, 10-Q, Financial Results, Net Loss, Liquidity, Going Concern, Convertible Notes, Working Capital Deficit, Medical Group